Daniel T. Scavilla is recorded as Board Member at DENTSPLY SIRONA Inc. (XRAY) since January 1, 2025, CEO at DENTSPLY SIRONA Inc. (XRAY) and Board Member at Globus Medical Inc (GMED) since June 7, 2023. The newest filing on record that lists Daniel T. Scavilla as Board Member at DENTSPLY SIRONA Inc. (XRAY) is dated April 9, 2025. DENTSPLY SIRONA Inc. reported in an 8-K filed November 6, 2025 that Daniel T. Scavilla was appointed interim principal financial officer, effective November 5, 2025. DENTSPLY SIRONA Inc. reported in an 8-K filed July 21, 2025 that Daniel T. Scavilla was appointed President and Chief Executive Officer, effective August 1, 2025. Globus Medical Inc reported in an 8-K filed July 21, 2025 that Daniel T. Scavilla resigned as Member of the Board of Directors, effective July 18, 2025. Equibles holds 6 filed executive changes naming Daniel T. Scavilla; each is listed under recent activity with its source filing. The proxy statement of Globus Medical Inc reports total compensation of $5,316,939 for Daniel T. Scavilla in fiscal 2025, including a base salary of $284,616. Disclosed compensation is on record for 9 fiscal years. Daniel T. Scavilla has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for DENTSPLY SIRONA Inc. on August 6, 2026. DENTSPLY SIRONA Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Globus Medical Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at DENTSPLY SIRONA Inc. includes Daniel Scavilla (CEO), Donald M. Casey (CEO), John P. Groetelaars (CEO) and 7 others.
“Additionally, on November 5, 2025, the Company appointed Daniel T. Scavilla, the Company’s President and Chief Executive Officer and a member of the Company’s Board of Directors, to the additional role of interim principal financial officer for purposes of the Company’s filings with the SEC, effective upon Mr. Garth’s departure.”
DENTSPLY SIRONA Inc. Form 8-K, filed November 6, 2025
· Read the filing
“On July 20, 2025, the Board of Directors (the "Board") of the Company appointed Daniel T. Scavilla as President and Chief Executive Officer of the Company, effective August 1, 2025 (the "Effective Date").”
DENTSPLY SIRONA Inc. Form 8-K, filed July 21, 2025
· Read the filing
Daniel T. Scavilla on recent calls
“Before we discuss the quarter, I'd like to welcome John Fortson to his first earnings call as Executive Vice President and Chief Financial Officer at Ben Splice-Arona.”
“Q1 marked the start of executing the Dentsply Sirona Return to Growth Action Plan. Our results reflect a business in transition and do not yet capture the actions underway intended to drive sustained profitable growth.”
“And it's funny, I've seen more day by day, right, as you kind of look at this with an urgency. And, you know, the reason for that, too, is just we have to drive urgency with the company, with the mindset.”
“This is my first earnings call since taking the CEO role on August 1. So I thought it would be appropriate to open with a few statements before progressing into the Q2 business results.”
